Receptos LLC
(NASDAQ : RCPT)

( )
RCPT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.74%178.160.7%$1431.81m
PFEPfizer Inc. 1.14%50.490.9%$1327.24m
ABBVAbbVie, Inc. 1.44%155.711.9%$1240.79m
BMYBristol-Myers Squibb Co. 1.49%76.931.0%$1167.46m
MRKMerck & Co., Inc. 2.14%92.340.7%$1088.82m
LLYEli Lilly & Co. 2.78%299.731.1%$823.15m
AZNAstraZeneca Plc 2.14%64.491.0%$478.91m
VERUVeru, Inc. 3.85%13.500.0%$403.25m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.38%140.460.0%$394.02m
GSKGlaxoSmithKline Plc 2.42%44.370.2%$223.17m
NVSNovartis AG 2.33%87.820.2%$219.85m
HZNPHorizon Therapeutics Plc 0.43%90.825.4%$198.56m
NVONovo Nordisk A/S -2.65%103.230.1%$166.43m
SGENSeagen Inc. 5.10%142.545.7%$163.52m
CTLTCatalent, Inc. -0.56%97.632.0%$158.65m

Company Profile

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.